Literature DB >> 25237381

A case of nonthrombotic pulmonary embolism after facial injection of hyaluronic Acid in an illegal cosmetic procedure.

Jong Geol Jang1, Kyung Soo Hong1, Eun Young Choi1.   

Abstract

Hyaluronic acid is widely used in medical procedures, particularly in cosmetic procedures administered by physicians or nonmedical personnel. The materials used for cosmetic procedures by physicians as well as illegally by non-medical personnel can cause nonthrombotic pulmonary embolism (NTPE). We report the case of a woman with acute respiratory failure, neurologic symptoms and petechiae after an illegal procedure of hyaluronic acid dermal filler performed by an unlicensed medical practitioner 3 days before symptom onset. Although a few cases of NTPE after injection of hyaluronic acid have been reported yet, this is the first typical case showing a NTPE manifestation after the facial injection of hyaluronic acid.

Entities:  

Keywords:  Cosmetics; Hyaluronic Acid; Pulmonary Embolism

Year:  2014        PMID: 25237381      PMCID: PMC4165666          DOI: 10.4046/trd.2014.77.2.90

Source DB:  PubMed          Journal:  Tuberc Respir Dis (Seoul)        ISSN: 1738-3536


Introduction

Hyaluronic acid is widely used in cosmetic procedures such as lip augmentation and the correction of facial wrinkles1,2. Here, we report the case of 35-year-old woman who developed dyspnea 3 days after an illegal hyaluronic acid dermal injection at a hair salon. She subsequently developed a confused mental state and petechial rash on the upper trunk, which is a typical clinical manifestation of nonthrombotic pulmonary embolism (NTPE). She was diagnosed with NTPE on the basis of her medical history and chest computed tomography (CT) results. She was fully recovered after conservative treatment. Although a few cases of NTPE after hyaluronic injection have been reported, the case with typical manifestation after facial area injection was rare.

Case Report

A 35-year-old woman who was previously healthy presented with abrupt onset of dyspnea and loss of consciousness for 5 minutes. Three days earlier, she received an illegal hyaluronic acid injection performed by an unlicensed medical practitioner into the dermis of the forehead and right cheek area. On physical examination, vital signs were as follows: body temperature, 36.8℃; blood pressure, 150/110 mm Hg; pulse rate, 127/min; respiratory rate, 28/min. Mental status was confused. Crackles were revealed in both lower lung fields. Routine laboratory test including liver function test and renal function test showed normal range of results. And, complete blood count was as follows: white blood cells, 21,080/µL (neutrophils 91%); hemoglobin, 11 g/dL; platelets, 240,000/µL. Troponin I, 0.16 ng/mL (normal, 0-0.1 ng/mL); CK-MB, 0.6 ng/mL (normal, 0-3.6 ng/mL); C-reactive protein, 5.307 mg/dL (normal, 0-0.5 mg/dL); D-dimer, 1.278 µg/mL (normal, 0-0.5 µg/mL); and N-terminal of the prohormone brain natriuretic peptide was 9,177 pg/mL (normal, 0-124 pq/mL). Arterial blood gas analysis via 15 L O2 reservoir bag was as follows: pH, 7.505; PCO2, 28.6 mm Hg; PO2, 66.1 mm Hg; HCO3-, 22.4 mmol/L. Plain chest radiography showed ground glass opacity and consolidation in both lung fields (Figure 1). Contrast-enhanced chest CT showed diffuse ground glass opacity in both lungs with dilatation of the pulmonary artery and right ventricle (Figure 2).
Figure 1

The plain chest radiography shows ground glass opacity and consolidation in both lung fields.

Figure 2

The contrast-enhanced chest computed tomography shows diffuse ground glass opacity in both lungs with dilatation of the pulmonary artery and right ventricle.

The patient was admitted to the intensive care unit and treated with mechanical ventilation owing to worsening hypoxemia. After several days, hemorrhagic eruptions occurred in anterior chest area. She was initially administered antibiotics, corticosteroids and diuretics. Hypoxemia was gradually improved. After 5 days, the result of initial blood culture showed no growth and there was no evidence of fever. Therefore, we could exclude the septic embolism and discontinued the antibiotics. She was weaned from mechanical ventilation. At the eighth day of hospital admission, she was discharged. After one month, she was completely improved and follow-up chest CT showed improvement of the previous pulmonary lesion without fibrosis (Figure 3).
Figure 3

One month later, the contrast-enhanced chest computed tomography shows an improvement of multifocal ground glass opacity in both lungs and a decreased size of the right ventricle.

Discussion

NTPE is defined as an embolization in the pulmonary circulation that can be caused by a variety of nonthrombotic embolic agents3. Different cell types (e.g., adipocytes, hematopoietic cells, amniotic cells, trophoblasts, and tumor cells), bacteria, fungi, foreign materials and gasses in the bloodstream may form an embolism in the pulmonary circulation4. NTPE can occur as a result of endothelial or parenchymal injury, causing inflammatory reactions in both systemic and pulmonary circulation3. Hyaluronic acid is approved dermal filler used to correct facial wrinkles and folds2. Because the chemical structure of hyaluronic acid is conserved among all species, the potential for immunologic reactions and implant rejection is negligible. Thus, hyaluronic acid is a very suitable material for use as a dermal filler1. Common side effects of dermal injections of hyaluronic acid include acneiform eruptions, lumps, inflammatory nodules, blue bumps (i.e., the Tyndall effect), vascular occlusion and granulomas5. However, rare cases of NTPE were reported after injection of hyaluronic acid. Two cases were reported pulmonary embolism after an intra-articular injection of methylprednisolone and hyaluronate6,7. In that case, shortness of breath occurred after a knee injection of hyaluronic acid and multiple patchy ground glass opacities were observed bilaterally in the middle and lower lobes of the lungs on chest CT; biopsy revealed an amorphous material containing hyaluronic acid with fibrin. Park et al.2 report a case of NTPE syndrome after an illegal hyaluronic acid vaginal injection3. Progressive dyspnea and decreased consciousness were observed 3 days after the injection; chest CT revealed bilateral ground glass opacity from the lower to apical zone, and biopsy confirmed a granulomatous foreign body reaction as observed in talc embolism2. This case was exhibited progressive dyspnea 3 days after hyaluronic acid dermal injection with hypoxemia, petechiae on the anterior chest wall and bilateral ground glass opacity on chest CT. In addition, chest CT showed basal dominant diffuse ground glass opacity, pulmonary artery dilatation, and cardiomegaly on the right side. Finding of this chest CT was distinguished from the finding of septic embolism which include multiple peripheral nodule, wedge-shaped peripheral leision, cavitation of nodules, and a feeding vessel sign8. Also, the ground glass opacity distribution did not correspond to idiopathic interstitial pneumonia. In the case reported by Park et al.2 NTPE was believed to have occurred in the systemic circulation, because hyaluronic acid was injected to the anterior wall of vagina where extensive venous plexus exists. In addition, Bhagat et al.7 suggest NTPE occurs as a result of hyaluronic acid embolisms in the systemic circulation due to damage to the synovium as a result of hyaluronic acid injection. Analyzing the results of cases of various illegal silicone injections shows pulmonary silicone embolism can occur via several mechanisms such excessive local tissue pressure induced by large-dose and high-pressure injection, local massage by an unlicensed practitioner, migration effect, or direct intravascular injections9. As review of the above mentioned cases suggests the NTPE in the present patient occurred as a result of damage to facial soft tissues due to inappropriate anatomical location and injection by an unlicensed practitioner as well as the inflow of hyaluronic acid embolisms directly into the blood vessels. Although hyaluronic acid binds to endothelial cells throughout the body, it binds particularly well to the pulmonary vasculature10. The symptoms in the present case were due to mechanical obstruction caused by hyaluronic acid bound to the endothelial cells of the pulmonary vasculature. Accordingly, CT showed dilatation of the pulmonary artery and right ventricular enlargement. NTPE was diagnosed on the basis of clinical conditions and chest CT. Severe hypoxia improved after conservative treatment with mechanical ventilation, which led to rapid recovery. Follow-up chest CT revealed improvements without fibrosis, confirming the diagnosis of NTPE rather than other possibilities as a result of interstitial lung disease. Although cases of NTPE caused by hyaluronic acid injection are occasionally reported, this is the first typical case shown to NTPE manifestation after facial injection of hyaluronic acid.
  10 in total

1.  Pulmonary embolism after intra-articular injection of methylprednisolone and hyaluronate.

Authors:  G Famularo; C Liberati; G D Sebastiani; S Polchi
Journal:  Clin Exp Rheumatol       Date:  2001 May-Jun       Impact factor: 4.473

2.  Arterial embolization caused by injection of hyaluronic acid (Restylane).

Authors:  S Schanz; W Schippert; A Ulmer; G Rassner; G Fierlbeck
Journal:  Br J Dermatol       Date:  2002-05       Impact factor: 9.302

3.  Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane).

Authors:  Seth L Matarasso; Jean D Carruthers; Mark L Jewell
Journal:  Plast Reconstr Surg       Date:  2006-03       Impact factor: 4.730

4.  Differential binding of hyaluronan on the surface of tissue-specific endothelial cell lines.

Authors:  Karol Szczepanek; Claudine Kieda; Joanna Cichy
Journal:  Acta Biochim Pol       Date:  2008-01-30       Impact factor: 2.149

Review 5.  Nonthrombotic pulmonary embolism.

Authors:  P G Jorens; E Van Marck; A Snoeckx; P M Parizel
Journal:  Eur Respir J       Date:  2009-08       Impact factor: 16.671

Review 6.  Massive systemic silicone embolism: a case report and review of literature.

Authors:  Eroston A Price; Harold Schueler; Joshua A Perper
Journal:  Am J Forensic Med Pathol       Date:  2006-06       Impact factor: 0.921

7.  Hyaluronic acid pulmonary embolism: a critical consequence of an illegal cosmetic vaginal procedure.

Authors:  Hyung Joo Park; Ki Hwan Jung; Sun Young Kim; Ju-Han Lee; Jin Yong Jeong; Je Hyeong Kim
Journal:  Thorax       Date:  2010-04       Impact factor: 9.139

8.  Pulmonary emboli from therapeutic sodium hyaluronate.

Authors:  Rajesh Bhagat; Rosanna M Forteza; Clay B Calcote; William T Williams; Steven A Bigler; Terry M Dwyer
Journal:  Respir Care       Date:  2012-03-12       Impact factor: 2.258

9.  Pulmonary septic emboli: diagnosis with CT.

Authors:  J E Kuhlman; E K Fishman; C Teigen
Journal:  Radiology       Date:  1990-01       Impact factor: 11.105

10.  Imaging of nonthrombotic pulmonary embolism: biological materials, nonbiological materials, and foreign bodies.

Authors:  Andreas Gunter Bach; Carlos Santiago Restrepo; Jasmin Abbas; Alberto Villanueva; María José Lorenzo Dus; Reinhard Schöpf; Hideaki Imanaka; Lukas Lehmkuhl; Flora Hau Fung Tsang; Fathinul Fikri Ahmad Saad; Eddie Lau; Jose Rubio Alvarez; Bilal Battal; Curd Behrmann; Rolf Peter Spielmann; Alexey Surov
Journal:  Eur J Radiol       Date:  2012-10-24       Impact factor: 3.528

  10 in total
  7 in total

1.  Soft-tissue Filler-associated Blindness: A Systematic Review of Case Reports and Case Series.

Authors:  Vandana Chatrath; Pooja S Banerjee; Greg J Goodman; Eqram Rahman
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-04-02

Review 2.  Regulation of the expression of proinflammatory cytokines induced by SARS-CoV-2.

Authors:  Xiang-Ning Zhang; Long-Ji Wu; Xia Kong; Bi-Ying Zheng; Zhe Zhang; Zhi-Wei He
Journal:  World J Clin Cases       Date:  2021-03-06       Impact factor: 1.337

Review 3.  Bridging a Century-Old Problem: The Pathophysiology and Molecular Mechanisms of HA Filler-Induced Vascular Occlusion (FIVO)-Implications for Therapeutic Interventions.

Authors:  Danny J Soares
Journal:  Molecules       Date:  2022-08-24       Impact factor: 4.927

Review 4.  Facial aesthetic injections in clinical practice: Pretreatment and posttreatment consensus recommendations to minimise adverse outcomes.

Authors:  Greg J Goodman; Steven Liew; Peter Callan; Sarah Hart
Journal:  Australas J Dermatol       Date:  2020-03-22       Impact factor: 2.875

5.  A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.

Authors:  Michael R Garvin; Christiane Alvarez; J Izaak Miller; Erica T Prates; Angelica M Walker; B Kirtley Amos; Alan E Mast; Amy Justice; Bruce Aronow; Daniel Jacobson
Journal:  Elife       Date:  2020-07-07       Impact factor: 8.713

Review 6.  Cerebral Embolism as a Result of Facial Filler Injections: A Literature Review.

Authors:  Hayson Chenyu Wang; Nanze Yu; Xiaojun Wang; Ruijia Dong; Xiao Long; Xin Feng; Jianle Li; Woffles T L Wu
Journal:  Aesthet Surg J       Date:  2022-02-15       Impact factor: 4.283

7.  Aspiration Before Tissue Filler-An Exercise in Futility and Unsafe Practice.

Authors:  Greg J Goodman; Mark R Magnusson; Peter Callan; Stefania Roberts; Sarah Hart; Frank Lin; Eqram Rahman; Cara B McDonald; Steven Liew; Cath Porter; Niamh Corduff; Michael Clague
Journal:  Aesthet Surg J       Date:  2022-01-01       Impact factor: 4.283

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.